ADial Pharmaceuticals

ADial Pharmaceuticals develops prescription medications for addictions and related disorders.

About

ADial Pharmaceuticals focuses on gene-specific medication to treat addiction and related disorders. The medications target multiple neurotransmitters and brain pathways, which can help change how substance abuse is treated. ADial’s two most advanced compounds specifically target alcohol abuse and dependence.

History

ADial Pharmaceuticals is a start-up, with headquarters in Charlottesville, Virginia, USA.

Ownership

Lindéngruppen’s stake in ADial Pharmaceuticals is approximately 10%. 

For more information please visit www.adialpharma.com